Add to ORKGLinezolid is a synthetic oxazolidinone antimicrobial drug. It is indicated for gram-positive infections and approved for the treatment of bacterial pneumonia, skin and skin structure infections, and vancomycin-resistant enterococcal (VRE) infections, including infections complicated by bacteremia. Linezolid does not have approval for the treatment of gram-negative infections, catheter-related bloodstream infections, or catheter site infections
Background. Resistance in Gram-positive pathogens is a worldwide problem. The decrease of activity o...
With fast emerging multiple drug resistant infections in dentistry, every dentist should be aware of...
Background. Antimicrobial resistance among Gram-positive organisms is rising. Resistant Staphylococc...
Linezolid is a synthetic oxazolidinone antimicrobial drug. It is indicated for gram-positive infecti...
Linezolid is the first of a new class of antimicrobial agents, the oxazolidinones, to be approved fo...
Linezolid is the first of a new class of antimicrobial agents, the oxazolidinones, to be approved fo...
Linezolid is an oxazolidinone indicated in the treatment of nosocomial and community-acquired pneumo...
The oxazolidinones are a new chemical class of synthetic antimicrobials characterized by a unique me...
Oxazolidinones are prominent among the new Gram-positive antimicrobial agents now becoming available...
The new oxazolidinone linezolid and other antimicrobial agents used to treat Gram-positive infection...
Gram-positive organisms, particularly staphylococci and streptococci, are responsible for the majori...
Linezolid is the main drug representative of the oxazolidinones, widely used in the clinical practic...
Treatment of Gram-positive bacterial infections is currently a therapeutic challenge because many of...
Seyed MohammadReza Hashemian,1,2 Tayebeh Farhadi,1 Mojdeh Ganjparvar3 1Chronic Respiratory Disease ...
Linezolid showed MIC50s and MIC90s of 1g/ml (for both) against Staphylococcus aureus. Two S. aureus ...
Background. Resistance in Gram-positive pathogens is a worldwide problem. The decrease of activity o...
With fast emerging multiple drug resistant infections in dentistry, every dentist should be aware of...
Background. Antimicrobial resistance among Gram-positive organisms is rising. Resistant Staphylococc...
Linezolid is a synthetic oxazolidinone antimicrobial drug. It is indicated for gram-positive infecti...
Linezolid is the first of a new class of antimicrobial agents, the oxazolidinones, to be approved fo...
Linezolid is the first of a new class of antimicrobial agents, the oxazolidinones, to be approved fo...
Linezolid is an oxazolidinone indicated in the treatment of nosocomial and community-acquired pneumo...
The oxazolidinones are a new chemical class of synthetic antimicrobials characterized by a unique me...
Oxazolidinones are prominent among the new Gram-positive antimicrobial agents now becoming available...
The new oxazolidinone linezolid and other antimicrobial agents used to treat Gram-positive infection...
Gram-positive organisms, particularly staphylococci and streptococci, are responsible for the majori...
Linezolid is the main drug representative of the oxazolidinones, widely used in the clinical practic...
Treatment of Gram-positive bacterial infections is currently a therapeutic challenge because many of...
Seyed MohammadReza Hashemian,1,2 Tayebeh Farhadi,1 Mojdeh Ganjparvar3 1Chronic Respiratory Disease ...
Linezolid showed MIC50s and MIC90s of 1g/ml (for both) against Staphylococcus aureus. Two S. aureus ...
Background. Resistance in Gram-positive pathogens is a worldwide problem. The decrease of activity o...
With fast emerging multiple drug resistant infections in dentistry, every dentist should be aware of...
Background. Antimicrobial resistance among Gram-positive organisms is rising. Resistant Staphylococc...